Skip to content

PALISADE BIO, INC.

PALI

CIK 0001357459

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$17.48M
−16.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.48
+97.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$13.07M
Q1 May 2026
Cash
$132.63M
Q1 May 2026
Total Debt
$87K
Q1 May 2026
Shares Outstanding
173.58M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings